Skip to main content
. 2022 Dec 1;23(23):15104. doi: 10.3390/ijms232315104
Ub Ubiquitin
Ub-G76 C-terminal glycine residue of the Ub
M1 Methionine-1
Oct4 Octamer-binding transcription factor-4
E1 Ub activating enzyme
E2 Ub binding enzyme
E3 Ub ligase
C Cysteine
RING Really interesting new gene
HECT Homologous to E6-AP COOH terminus
RBR RING between RING
Nedd4 Neuronal precursor cell-expressed developmentally downregulated 4
HERC HECT and RLD-containing
RLD RCC1-like domains
UPS Ubiquitin proteasome system
Ube2c Ubiquitin-conjugating enzyme 2C
Gp78 Glycoprotein 78
ERAD Endoplasmic reticulum-associated degradation
MDM2/HDM2 Mouse double minute 2/human homolog of mouse double minute 2
TP53 Tumor protein p53
COP1 Constitutive photomorphogenesis protein 1
Pirh2 P53-induced protein with a RING-H2 domain
CHIP Co-chaperone carboxyl terminus Hsp70/90-interacting protein
Skp2 S-phase kinase-associated protein 2
Cul1 Cullin 1
Rbx1 Ring box 1
Skp1 S-phase kinase-associated protein 1
SCFSkp2 complex The RING-type E3 complex Skp1–Cul1–Skp2
FOXO1 Forkhead box O1
Yap Yes-associated protein
MTH1 MutT homolog-1
ROS Oxygen species
IAPs Inhibitor of apoptosis-related proteins
XIAP X-linked inhibitor of apoptosis
cIAP1/2 Cellular inhibitor of apoptosis proteins 1 and 2
ML-IAP Melanoma inhibitor of apoptosis
ILP2 Inhibitor of apoptosis-like protein 2
BIR Baculoviral IAP repeat
Wwp2 WW domain-containing E3 Ubiquitin protein ligase 2
AIP-2 Atrophin-1-interacting protein 2
PTEN Phosphatase and tensin homolog
Nedd4-1 Neural precursor cell expressed developmentally downregulated-4-1
FDA Federal Drug Administration
PROTAC Proteolysis-targeting chimera
CRBN Cereblon
mCRPC Metastatic castration resistant prostate cancer
CRL4CRBN E3 complex CUL4–DDB1–CRBN–RBX1 E3 complex
GSPT1 G1-to S phase transition 1
EGCG Epigalocatechin-3-gallate
NSCLC Non-small-cell lung cancer
I3C Indole-3-carbinol
HOIP Hoil-1-interacting protein
EMA European Medicines Agency